Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 14 | 2019 | 930 | 2.950 |
Why?
|
| Nerve Net | 10 | 2019 | 115 | 2.680 |
Why?
|
| Models, Theoretical | 5 | 2019 | 126 | 1.610 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2018 | 242 | 1.280 |
Why?
|
| Data Interpretation, Statistical | 3 | 2019 | 103 | 1.040 |
Why?
|
| Models, Neurological | 3 | 2019 | 115 | 0.810 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2019 | 1218 | 0.730 |
Why?
|
| Multivariate Analysis | 4 | 2018 | 637 | 0.720 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 3 | 2014 | 26 | 0.690 |
Why?
|
| Databases, Factual | 4 | 2019 | 332 | 0.670 |
Why?
|
| Software | 1 | 2018 | 109 | 0.630 |
Why?
|
| Algorithms | 4 | 2018 | 462 | 0.580 |
Why?
|
| Pesticides | 2 | 2017 | 189 | 0.580 |
Why?
|
| Occupational Exposure | 2 | 2017 | 224 | 0.570 |
Why?
|
| Models, Biological | 3 | 2015 | 373 | 0.540 |
Why?
|
| Feedback | 1 | 2015 | 33 | 0.530 |
Why?
|
| Nicotine | 1 | 2017 | 157 | 0.520 |
Why?
|
| Models, Statistical | 3 | 2017 | 163 | 0.510 |
Why?
|
| Models, Cardiovascular | 1 | 2014 | 27 | 0.500 |
Why?
|
| Humans | 31 | 2019 | 29093 | 0.490 |
Why?
|
| Emigrants and Immigrants | 1 | 2017 | 235 | 0.490 |
Why?
|
| Caudate Nucleus | 1 | 2014 | 23 | 0.480 |
Why?
|
| Schizophrenia | 1 | 2014 | 38 | 0.480 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2018 | 43 | 0.460 |
Why?
|
| Hypertension | 3 | 2014 | 906 | 0.420 |
Why?
|
| Computer Graphics | 1 | 2011 | 11 | 0.410 |
Why?
|
| Computer Simulation | 5 | 2019 | 207 | 0.400 |
Why?
|
| Myelin Sheath | 1 | 2010 | 6 | 0.380 |
Why?
|
| Adult | 14 | 2019 | 8420 | 0.350 |
Why?
|
| Longitudinal Studies | 2 | 2013 | 720 | 0.350 |
Why?
|
| Male | 19 | 2019 | 17807 | 0.320 |
Why?
|
| Rest | 3 | 2017 | 49 | 0.310 |
Why?
|
| Regression Analysis | 3 | 2017 | 274 | 0.310 |
Why?
|
| Neural Pathways | 3 | 2017 | 97 | 0.300 |
Why?
|
| Female | 17 | 2019 | 18164 | 0.300 |
Why?
|
| Military Personnel | 2 | 2018 | 85 | 0.300 |
Why?
|
| Memory, Short-Term | 3 | 2016 | 59 | 0.280 |
Why?
|
| Young Adult | 7 | 2019 | 2402 | 0.280 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2017 | 23 | 0.280 |
Why?
|
| Patient Admission | 2 | 2017 | 53 | 0.270 |
Why?
|
| Alcohol Drinking | 2 | 2019 | 244 | 0.260 |
Why?
|
| Comprehension | 2 | 2015 | 19 | 0.240 |
Why?
|
| Cognition | 3 | 2016 | 526 | 0.230 |
Why?
|
| Aged | 10 | 2019 | 9487 | 0.220 |
Why?
|
| Neurons | 2 | 2015 | 394 | 0.200 |
Why?
|
| Brain Mapping | 3 | 2018 | 182 | 0.200 |
Why?
|
| Allostasis | 2 | 2017 | 11 | 0.190 |
Why?
|
| Acoustic Stimulation | 2 | 2018 | 125 | 0.190 |
Why?
|
| Photography | 1 | 2019 | 33 | 0.180 |
Why?
|
| Photic Stimulation | 1 | 2019 | 155 | 0.170 |
Why?
|
| Blood Glucose | 2 | 2019 | 466 | 0.170 |
Why?
|
| Aging | 2 | 2015 | 881 | 0.160 |
Why?
|
| Obesity | 2 | 2018 | 1063 | 0.160 |
Why?
|
| Middle Aged | 9 | 2019 | 10829 | 0.160 |
Why?
|
| Time Factors | 4 | 2017 | 2001 | 0.160 |
Why?
|
| Normal Distribution | 2 | 2015 | 12 | 0.160 |
Why?
|
| Electroencephalography | 1 | 2017 | 71 | 0.160 |
Why?
|
| Acetylcholinesterase | 1 | 2017 | 17 | 0.150 |
Why?
|
| Butyrylcholinesterase | 1 | 2017 | 15 | 0.150 |
Why?
|
| Probability | 1 | 2017 | 150 | 0.150 |
Why?
|
| Cotinine | 1 | 2017 | 45 | 0.150 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 3717 | 0.150 |
Why?
|
| Temporal Lobe | 1 | 2017 | 41 | 0.150 |
Why?
|
| Oxygen | 1 | 2017 | 139 | 0.140 |
Why?
|
| Hospital Mortality | 1 | 2017 | 186 | 0.140 |
Why?
|
| Infant, Newborn | 3 | 2017 | 598 | 0.140 |
Why?
|
| Overweight | 1 | 2018 | 256 | 0.140 |
Why?
|
| Insulin Resistance | 1 | 2019 | 449 | 0.140 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 366 | 0.140 |
Why?
|
| Threshold Limit Values | 1 | 2015 | 2 | 0.130 |
Why?
|
| Systole | 1 | 2015 | 87 | 0.130 |
Why?
|
| Circadian Rhythm | 1 | 2015 | 43 | 0.130 |
Why?
|
| Diastole | 1 | 2015 | 90 | 0.130 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 38 | 0.130 |
Why?
|
| Retrospective Studies | 3 | 2017 | 3111 | 0.130 |
Why?
|
| Weight Loss | 1 | 2018 | 413 | 0.130 |
Why?
|
| Psychotropic Drugs | 1 | 2014 | 10 | 0.130 |
Why?
|
| Sensation | 1 | 2015 | 53 | 0.130 |
Why?
|
| Visual Perception | 1 | 2015 | 112 | 0.120 |
Why?
|
| Critical Illness | 1 | 2014 | 87 | 0.120 |
Why?
|
| Hippocampus | 1 | 2014 | 185 | 0.110 |
Why?
|
| Odds Ratio | 4 | 2017 | 447 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 1013 | 0.100 |
Why?
|
| Body Weight | 1 | 2013 | 290 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2015 | 804 | 0.100 |
Why?
|
| Politics | 1 | 2011 | 20 | 0.100 |
Why?
|
| Hispanic Americans | 1 | 2017 | 904 | 0.100 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 2010 | 1 | 0.100 |
Why?
|
| Anisotropy | 1 | 2010 | 10 | 0.100 |
Why?
|
| Animals | 4 | 2015 | 7297 | 0.090 |
Why?
|
| Rhinitis | 1 | 2010 | 11 | 0.090 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 268 | 0.090 |
Why?
|
| African Americans | 2 | 2016 | 1373 | 0.090 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2010 | 86 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2015 | 1687 | 0.090 |
Why?
|
| Family Relations | 1 | 2008 | 22 | 0.080 |
Why?
|
| Prostate-Specific Antigen | 1 | 2008 | 61 | 0.080 |
Why?
|
| Healthcare Disparities | 1 | 2011 | 153 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 231 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 464 | 0.080 |
Why?
|
| Diet | 1 | 2010 | 354 | 0.080 |
Why?
|
| Health Education | 1 | 2008 | 121 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 1379 | 0.080 |
Why?
|
| Social Support | 1 | 2008 | 163 | 0.080 |
Why?
|
| Risk Factors | 4 | 2019 | 3531 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 88 | 0.070 |
Why?
|
| Mass Screening | 1 | 2008 | 223 | 0.070 |
Why?
|
| Mississippi | 2 | 2019 | 24 | 0.070 |
Why?
|
| Linear Models | 1 | 2007 | 426 | 0.070 |
Why?
|
| C-Reactive Protein | 2 | 2017 | 232 | 0.070 |
Why?
|
| Child Nutrition Disorders | 1 | 2005 | 4 | 0.070 |
Why?
|
| Prealbumin | 1 | 2005 | 8 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2017 | 469 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2017 | 1167 | 0.070 |
Why?
|
| Serum Albumin | 1 | 2005 | 53 | 0.070 |
Why?
|
| Heart Rate | 2 | 2017 | 315 | 0.070 |
Why?
|
| Cerebral Palsy | 1 | 2005 | 52 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 441 | 0.060 |
Why?
|
| African Continental Ancestry Group | 2 | 2019 | 350 | 0.060 |
Why?
|
| United States | 4 | 2017 | 3630 | 0.060 |
Why?
|
| Infant | 2 | 2017 | 969 | 0.060 |
Why?
|
| Child | 3 | 2017 | 2219 | 0.060 |
Why?
|
| Anthropometry | 2 | 2016 | 82 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 726 | 0.050 |
Why?
|
| North Carolina | 2 | 2017 | 1423 | 0.050 |
Why?
|
| Adolescent | 3 | 2017 | 3254 | 0.050 |
Why?
|
| Cues | 1 | 2019 | 67 | 0.040 |
Why?
|
| Vasopressins | 1 | 2017 | 17 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2017 | 33 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2017 | 30 | 0.040 |
Why?
|
| Epinephrine | 1 | 2017 | 41 | 0.040 |
Why?
|
| Diet, Reducing | 1 | 2018 | 90 | 0.040 |
Why?
|
| Veterans | 1 | 2017 | 50 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2017 | 73 | 0.040 |
Why?
|
| Resistance Training | 1 | 2018 | 70 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 68 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2017 | 225 | 0.040 |
Why?
|
| Autonomic Nervous System | 1 | 2017 | 42 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 113 | 0.040 |
Why?
|
| Demography | 1 | 2016 | 104 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2016 | 89 | 0.040 |
Why?
|
| Leptin | 1 | 2016 | 66 | 0.040 |
Why?
|
| Baroreflex | 1 | 2017 | 84 | 0.040 |
Why?
|
| Prevalence | 1 | 2019 | 896 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2016 | 165 | 0.030 |
Why?
|
| Adiponectin | 1 | 2016 | 103 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2017 | 279 | 0.030 |
Why?
|
| Triglycerides | 1 | 2016 | 214 | 0.030 |
Why?
|
| Angiotensin I | 1 | 2017 | 262 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2018 | 229 | 0.030 |
Why?
|
| Research Design | 1 | 2017 | 286 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 1356 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2014 | 52 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2017 | 422 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2014 | 72 | 0.030 |
Why?
|
| Life Style | 1 | 2016 | 364 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2015 | 379 | 0.030 |
Why?
|
| Action Potentials | 1 | 2014 | 174 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2019 | 1305 | 0.030 |
Why?
|
| Urban Health | 1 | 2013 | 14 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 454 | 0.030 |
Why?
|
| Incidence | 1 | 2016 | 1119 | 0.030 |
Why?
|
| Exercise | 1 | 2018 | 591 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 641 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 2108 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 631 | 0.020 |
Why?
|
| Health Policy | 1 | 2011 | 79 | 0.020 |
Why?
|
| Captan | 1 | 2010 | 1 | 0.020 |
Why?
|
| Petroleum | 1 | 2010 | 1 | 0.020 |
Why?
|
| Diazinon | 1 | 2010 | 2 | 0.020 |
Why?
|
| Iowa | 1 | 2010 | 9 | 0.020 |
Why?
|
| Acetamides | 1 | 2010 | 7 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 1604 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2013 | 865 | 0.020 |
Why?
|
| Information Seeking Behavior | 1 | 2008 | 6 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2008 | 140 | 0.020 |
Why?
|
| Health Surveys | 1 | 2008 | 191 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2008 | 222 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2008 | 154 | 0.020 |
Why?
|
| Decision Making | 1 | 2008 | 180 | 0.020 |
Why?
|
| Logistic Models | 1 | 2008 | 727 | 0.020 |
Why?
|
| Nutrition Assessment | 1 | 2005 | 54 | 0.020 |
Why?
|
| European Continental Ancestry Group | 1 | 2008 | 1131 | 0.020 |
Why?
|